Literature DB >> 96903

Diminished cellular immunity due to impaired nutrition in oesophageal carcinoma.

A A Haffejee, I B Angorn, P P Brain, J Duursma, L W Baker.   

Abstract

The nutritional status of 15 Negro patients suffering from unresectable carcinoma of the midthoracic oesophagus was evaluated before and after palliative pulsion intubation. All were shown to be in negative nitrogen balance and to have a compromised non-specific cellular immune response. Correction of protein-calorie malnutrition and the achievement of positive nitrogen balance were associated with an increase in absolute lymphocyte and T lymphocyte numbers and a significant increase in lymphocyte response to PHA. The improvement in immunological reactivity occurred without any attempt at therapeutic reduction in tumour bulk.

Entities:  

Mesh:

Year:  1978        PMID: 96903     DOI: 10.1002/bjs.1800650710

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Parenteral nutrition before surgery?

Authors: 
Journal:  Br Med J       Date:  1979-12-15

Review 2.  Nutrition in the cancer patient: a review.

Authors:  J W Dickerson
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

3.  Post operative stimulation of cell mediated immunity.

Authors:  J A Smith; W S Hendry; J L Duncan; J N Norman
Journal:  Klin Wochenschr       Date:  1985-10-01

4.  Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality.

Authors:  R Brown; J Bancewicz; J Hamid; N J Patel; C A Ward; R J Farrand; R S Pumphrey; M Irving
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

5.  Endoscopically defined treatment strategies in patients with locally advanced esophageal cancer.

Authors:  J A Greager; P E Donahue; K Reichard; V Kucich; M Lubienski; W Barker; H M Reyes
Journal:  Surg Endosc       Date:  1994-05       Impact factor: 4.584

Review 6.  Nutritional support in patients with oesophageal cancer.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2009-06-24       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.